Open Access 01-12-2020 | Letter
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Published in: Trials | Issue 1/2020
Login to get access